The evolution and metamorphosis of the pharmacy practice model

American Journal of Health-System Pharmacy

Volumn 66, Issue 16, 2009, Pages 1437-1446

  Abramowitz, Paul W ^a,b  

^a UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

^b UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMBULATORY CARE; CERTIFICATION; CONFERENCE PAPER; COST OF ILLNESS; DRUG MONITORING; DRUG SAFETY; EDUCATION PROGRAM; HISTORY; HOSPITAL PHARMACY; PATIENT COMPLIANCE; PHARMACEUTICAL CARE; PHARMACIST; PHARMACY; POSTGRADUATE EDUCATION; PRIORITY JOURNAL; PRODUCTIVITY; PROFESSIONAL PRACTICE;

EID: 69249198698     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.2146/ajhp090286     Document Type: Conference Paper

References (48)

1. Toffler A. Future shock. New York: Random House; 1970.
2. Smith WE. The future role of the hospital pharmacist in the patient care area. Am J Hosp Pharm. 1967; 24:228-231
3. Oddis JA. Commitment and involvement. Am J Hosp Pharm. 1970; 27:454-458
4. Hepler CD, Strand LM. Opportunities and responsibilities in pharmaceutical care. Am J Hosp Pharm. 1990; 47:533-543
5. American Society of Health-System Pharmacists. List of states by statutory and regulatory authority (updated August 2006). www.ashp.org/s-ashp/ docs/files/GAD-cdtm8-06chart.pdf (accessed 2009 Apr 8).
6. Hammond RW, Schwartz AH, Campbell MJ et al. Collaborative drug therapy management by pharmacists - 2003. Pharmacotherapy. 2003; 23:1210-1225 (Pubitemid 37158791)
7. Thomas J III, Bharmal M, Lin SW et al. Survey of pharmacist collaborative drug therapy management in hospitals. Am J Health-Syst Pharm. 2006; 63:2489-2499 (Pubitemid 46391145)
8. Yuksel N, Eberhart G, Bungard TJ. Prescribing by pharmacists in Alberta. Am J Health-Syst Pharm. 2008; 65:2126-2132
9. Royal Pharmaceutical Society of Great Britain. Pharmacist prescriber pack. www.rpsgb.org.uk/pdfs/pharmprescriberpack.pdf (accessed 2009 Apr 7).
10. Royal Pharmaceutical Society of Great Britain. Pharmacist prescribing, www.rpsgb.org/worldofpharmacy/currentdevelopmentsinpharmacy/ pharmacistprescribing.pdf (accessed 2009 Apr 7).
11. The Lewin Group. Medication therapy management services: a critical review. J Am Pharm Assoc. 2005; 45:580-587
12. Buffington DE. Future of medication therapy management services in delivering patient-centered care. Am J Health-Syst Pharm. 2007; 64(suppl 10):S10-2.
13. Westrick SC, Mount JK, Watcharadamrongkun S et al. Pharmacy stages of involvement in pharmacy-based immunization services: results from a 17-state survey. J Am Pharm Assoc. 2008; 48:764-73.
14. Cranor CW, Bunting BA, Christensen DB. The Asheville Project: long-term clinical and economic outcomes of a community pharmacy diabetes care program. J Am Pharm Assoc. 2003; 43:173-184
15. Bond CA, Raehl CL. Pharmacist-provided anticoagulation management in United States hospitals: death rates, length of stay, Medicare charges, bleeding complications, and transfusions. Pharmacotherapy. 2004; 24:953-963
16. Bond CA, Raehl CL. Clinical and economic outcomes of pharmacist-managed aminoglycoside or vancomycin therapy. Am J Health-Syst Pharm. 2005; 62:1596-605.
17. Bond CA, Raehl CL. Clinical and economic outcomes of pharmacist-managed antimicrobial prophylaxis in surgical patients. Am J Health-Syst Pharm. 2007; 64:1935-1942
18. Bond CA, Raehl CL. Clinical and economic outcomes of pharmacist-managed antiepileptic drug therapy. Pharmacotherapy. 2006; 26:1369-1378 (Pubitemid 44521721)
19. Bond CA, Raehl CL, Franke T. Clinical pharmacy services, pharmacy staffing, and the total cost of care in United States hospitals. Pharmacotherapy. 2000; 20:609-621 (Pubitemid 30387676)
20. Bond CA, Raehl CL. Clinical pharmacy services, pharmacy staffing, and adverse drug reactions in United States hospitals. Pharmacotherapy. 2006; 26:735-747
21. Perez A, Doloresco F, Hoffman JM et al. Economic evaluations of clinical pharmacy services: 2001-2005. Pharmacotherapy. 2008; 28:285e-323e.
22. Breland B. Believing what we know: pharmacy provides value. Am J Health-Syst Pharm. 2007; 64:e18-29. (Pubitemid 47216197)
23. Pierpaoli PG. An iconoclastic perspective on progress in pharmacy. Am J Health-Syst Pharm. 1995; 52:1763-1770
24. Kaplan RS, Norton D. The balanced scorecard: measures that drive performance. Harvard Bus Rev. 1992; 70:71-80.
25. Bahl V, McCreadie SR, Stevenson JG. Developing dashboards to measure and manage inpatient pharmacy costs. Am J Health-Syst Pharm. 2007; 64:1859-1866 (Pubitemid 350202220)
26. Puckett W. Management pearls 2006. Paper presented at ASHP Midyear Clinical Meeting. Anaheim, CA; 2006 Dec.
27. Oden B, Kromelis M. A quality dashboard utilizing reported adverse drug events, pharmacists interventions and point of care alerts in a private pediatric hospital. Paper presented at ASHP Mid-year Clinical Meeting. Atlanta, GA; 2002 Dec.
28. Yablon M, Chen S, Shane R et al. Integrating a dashboard indicator reporting system into a primary care pharmacy practice. Paper presented at ASHP Mid-year Clinical Meeting. New Orleans, LA; 2001 Dec.
29. Cipolle R, Strand L, Moley P. Pharmaceutical care practice, the clinicians guide. 2nd ed. New York: McGraw Hill Medical; 2004:202-224
30. Morello CM, Zadvorny EB, Cording MA et al. Development and clinical outcomes of pharmacist-managed diabetes care clinics. Am J Health-Syst Pharm. 2006; 63:1325-1331 (Pubitemid 44116785)
31. Nkansah NT, Brewer JM, Connors R et al. Clinical outcomes of patients with diabetes mellitus receiving medication management by pharmacists in an urban private physician practice. Am J Health-Syst Pharm. 2008; 65:145-149
32. Poon IO, Lal L, Brown EN et al. The impact of pharmacist-managed oral anticoagulation therapy in older veterans. J Clin Pharm Ther. 2007; 32:21-29 (Pubitemid 46213938)
33. Garwood CL, Dumo P, Baringhaus SN et al. Quality of anticoagulation care in patients discharged from a pharmacist-managed anticoagulation clinic after stabilization of warfarin therapy. Pharmacotherapy. 2008; 28:20-26
34. Finley PR, Rens HR, Pont JT et al. Impact of a collaborative pharmacy practice model on the treatment of depression in primary care. Am J Health-Syst Pharm. 2002; 59:1518-1526 (Pubitemid 34864362)
35. Benavides S, Rodriguez JC, Maniscalco-Feichtl M. Pharmacist involvement in improving asthma outcomes in various healthcare settings: 1997 to present. Ann Pharmacother. 2008; 43:85-97.
36. Hunt JS, Siemienczuk J, Pape G et al. A randomized controlled trial of team-based care: impact of physician-pharmacist collaboration on uncontrolled hypertension. J Gen Intern Med. 2008; 23:1966-1972
37. Zellmer W. Unresolved issues in pharmacy. Am J Health-Syst Pharm. 2005; 62:259-265
38. Shane RR. Pharmacy without walls. Am J Health-Syst Pharm. 1996; 53:418-425
39. Koecheler JA, Abramowitz PA, Swim SE et al. Indicators for the selection of ambulatory patients who warrant pharmacist monitoring. Am J Hosp Pharm. 1989; 46:729-732
40. Lobas NH, Lepinski PW, Abramowitz PW. Effects of pharmaceutical care on medication cost and quality of patient care in an ambulatory-care clinic. Am J Hosp Pharm. 1992; 49:1681-1688
41. Ellis SL, Billups SJ, Malone DC et al. Types of interventions made by clinical pharmacists in the IMPROVE study. Pharmacotherapy. 2000; 20:429-435
42. Ellis SL, Carter BL, Malone DC et al. Clinical and economic impact of ambulatory care clinical pharmacists in management of dyslipidemia in older adults: the IMPROVE study. Pharmacotherapy. 2000; 20:1508-1516
43. Wu JY, Leung WY, Chang S et al. Effectiveness of telephone counselling by a pharmacist in reducing mortality in patients receiving polypharmacy: randomised controlled trial. BMJ. 2006; 333:522-525 (Pubitemid 44408460)
44. Choe HM, Mitrovich S, Dubay D et al. Proactive case management of high-risk patients with type 2 diabetes mellitus by a clinical pharmacist: a randomized controlled trial. Am J Manag Care. 2005; 11:253-260 (Pubitemid 40569748)
45. Wittkowsky AK, Nutescu EA, Blackburn J et al. Outcomes of oral anticoagulant therapy managed by telephone vs in-office visits in an anticoagulation clinic setting. Chest. 2006; 130:1385-1389 (Pubitemid 44786730)
46. Godwin HN. To a new beginning from converging paths. Am J Hosp Pharm. 1991; 48:1697-1703
47. Manasse HR Jr. Ideals and idealists: striving to achieve our societal imperative. Am J Health-Syst Pharm. 2007; 64:1685-1692
48. Saseen JJ, Grady SE, Hansen LB et al. Future clinical pharmacy practitioners should be board-certified specialists. Pharmacotherapy. 2006; 26:1816-1825